In vitro antifungal activities of the new triazole UR-9825 against clinically important filamentous fungi
- PMID: 11502542
- PMCID: PMC90705
- DOI: 10.1128/AAC.45.9.2635-2637.2001
In vitro antifungal activities of the new triazole UR-9825 against clinically important filamentous fungi
Abstract
We used a modified reference microdilution method (the M-38P method) to evaluate the in vitro activities of the new triazole UR-9825 in comparison with those of amphotericin B against 77 strains of opportunistic filamentous fungi. UR-9825 was clearly more active than amphotericin B against all fungi except Fusarium solani and Scytalidium spp. Notably, UR-9825 had low MICs for Aspergillus fumigatus and Paecilomyces lilacinus (MICs at which 90% of isolates are inhibited, 0.125 microg/ml for both species).
References
-
- Bartroli J, Turmo E, Algueró M, Boncompte E, Vericat M L, Conte L, Ramis J, Merlos M, García-Rafanell J, Forn J. New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones. J Med Chem. 1998;41:1869–1882. - PubMed
-
- Castro L G, Salebian A, Sotto M N. Hyalohyphomycosis by Paecilomyces lilacinus in a renal transplant patient and a review of human Paecilomyces species infections. J Med Vet Mycol. 1990;28:15–26. - PubMed
-
- Clancy C J, Nguyen M H. In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species. Eur J Clin Microbiol Infect Dis. 1998;17:573–575. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous